Sonnet BioTherapeutics (NASDAQ:SONN) Participates in Virtual Investor "What This Means" Segment Hosted by JTC Team
Sonnet BioTherapeutics (NASDAQ:SONN) Participates in Virtual Investor "What This Means" Segment Hosted by JTC Team
The Virtual Investor "What This Means" segment featuring Sonnet BioTherapeutics is now available here. Additional videos from the "What This Means" series are available on demand at .Watch the "What This Means" segment here
在這裏觀看“What This Means”部分
FRENCHTOWN, NJ / ACCESSWIRE / July 24, 2024 / JTC Team ("JTC"), a fully integrated corporate communications and investor relations firm, today released a Virtual Investor "What This Means" segment featuring Sonnet BioTherapeutics, Inc. (Nasdaq:SONN), a clinical-stage company developing targeted immunotherapeutic drugs.
NJ的FRENCHTOWN / ACCESSWIRE / 2024年7月24日 / 全面一體化的企業通信和投資者關係公司JTC Team（“JTC”）今天發佈了一個虛擬投資者“What This Means”部分，重點介紹正在開發靶向免疫治療藥物的臨床階段的公司Sonnet BioTherapeutics，Inc. （納斯達克：SONN）。
As part of the "What This Means" segment, Pankaj Mohan, PhD, Founder and Chief Executive Officer, Richard Kenney, M.D., Chief Medical Officer and Dr. Gael Hedou, Chief Operating Officer of Sonnet BioTherapeutics, discuss highlights from the company's recently announced encouraging data from their ongoing Phase 1b/2a clinical trial of SON-080 in chemotherapy-induced Peripheral Neuropathy (CIPN).
作爲“What This Means”部分的一部分，Sonnet BioTherapeutics的創始人兼首席執行官Pankaj Mohan，博士，首席醫療官Richard Kenney萬.D.和首席運營官Gael Hedou博士討論了該公司最近公佈的 SON-080 用於化療誘導的周圍神經病變（CIPN）的一項正在進行的1b/2a臨床試驗鼓舞人心的數據亮點。
The Virtual Investor "What This Means" segment featuring Sonnet BioTherapeutics is now available here. Additional videos from the "What This Means" series are available on demand at .
現在可以在此處查看Sonnet BioTherapeutics的虛擬投資者“What This Means”部分。 “What This Means”系列的其他視頻可按需提供。
About JTC Team
關於JTC團隊
JTC is a fully integrated corporate communications firm that is dedicated to helping you tell your story to the right audiences in order to build awareness. JTC has developed a reputation of excellence for executing robust communication strategies that deliver results. The Company partners with both public and private companies across the Life Sciences and Technology industries to help raise awareness and build stakeholder value. For more information, please visit or connect with the company on X and LinkedIn.
JTC是一家全面一體化的企業通信公司，致力於幫助您向正確的受衆講述您的故事，以建立知名度。JTC已經建立了卓越的聲譽，因爲執行了結實的傳播戰略，取得了良好的成果。本公司與生命科學和科技行業的公共和私人企業合作，以幫助提高知名度並建立利益相關者的價值。欲了解更多信息，請訪問網站或在X和LinkedIn上關注公司。
Contact:
聯繫方式：
Jenene Thomas
JTC Team, LLC
T: +1 (833) 475-8247
jtc@jtcir.com
Jenene Thomas
JTC Team，LLC
T：+1（833）475-8247
jtc@jtcir.com
SOURCE: JTC Team, LLC
來源：JTC團隊，有限責任公司
譯文內容由第三人軟體翻譯。